2,992
回編集
差分
ナビゲーションに移動
検索に移動
→New vaccine development
*'''Non-replicating viral vector YF vaccine''' has been under development. '''Phase 1''' trial of '''YF protein-producing Modified Vaccinia Ankara-Bavarian Nordic virus''' has been completed but has not been reported in peer-reviewed journals.
{{quote
|content=[[NCT02743455 - A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers https://classic.clinicaltrials.gov/ct2/show/NCT02743455]]
}}
